Bed Count Isn't a Good Proxy for Hospital Purchasing Power Anymore | NPLUS Global

For decades, bed count did a reasonable job of standing in for a hospital's purchasing power. It correlated loosely with patient volume, staff headcount, service line breadth, and capital budget — enough that sales and marketing teams could build territory plans, account tiers, and TAM models around it without much argument. A 400-bed hospital was assumed to buy more than a 90-bed one, more or less across the board.

That assumption is aging badly. It's not that bed count has become meaningless — it's that the world it was built to describe has changed shape underneath it, and a lot of commercial teams are still segmenting as if nothing moved.

The Proxy Made Sense Before the Industry Reorganized Itself

Bed count worked as a shorthand because, historically, most clinical and financial activity happened inside the four walls it was counting. Inpatient volume drove revenue. Capital equipment purchases were tied to inpatient service lines. Staffing scaled with beds. If you wanted a fast, defensible way to rank accounts without doing deep account research on every facility, licensed bed count was a fine starting point.

It also matched how healthcare organizations were structured at the time: standalone hospitals or small local systems, each making its own purchasing decisions, each with a facilities footprint that roughly matched its clinical footprint. In that world, the hospital was the purchasing unit.

That's the part that's broken down.

Purchasing Power Has Moved Up, Out, and Sideways

A growing share of hospitals now operate as nodes in a much larger system, and purchasing decisions increasingly happen above the facility level. Supply chain, capital equipment, IT infrastructure, and often clinical technology decisions get made at the system or regional level, sometimes through a centralized value analysis committee that has never set foot in a specific building. A 120-bed community hospital that's part of a large regional IDN can have more effective purchasing leverage — and a completely different buying process — than a 300-bed standalone hospital making its own decisions independently. Bed count tells you nothing about which of those two situations you're looking at.

At the same time, a substantial amount of clinical volume and spend has migrated out of inpatient beds entirely. Ambulatory surgery centers, outpatient imaging, infusion centers, urgent care networks, and physician group acquisitions have absorbed procedures and patient volume that used to happen inpatient. Many health systems have been deliberately shrinking or flattening their inpatient bed footprint while expanding aggressively on the outpatient side, because that's where margin and growth increasingly live. It's becoming common for a system to close or consolidate inpatient beds in one facility while simultaneously opening several outpatient sites in the surrounding market — a net purchasing power increase that a bed-count model would read as a decline.

Then there's the sideways movement: horizontal integration through M&A, joint ventures, and management agreements that link facilities financially and operationally without necessarily changing what's licensed on paper at any single site. Two hospitals can look identical in a bed-count field and sit on completely different sides of a purchasing relationship — one folded into a system with centralized procurement and shared IT infrastructure, the other still functioning as an independent decision-maker for the same category of spend.

What Teams Are Actually Reaching For Instead

Commercial teams that have noticed the gap aren't abandoning facility-level data — they're layering it with signals that map more closely to how buying actually happens now. A few patterns show up repeatedly in how more sophisticated teams are rebuilding segmentation:

System affiliation and hierarchy is doing more work than raw size. Knowing that a facility rolls up into a specific IDN, and where it sits in that system's decision-making structure, often predicts buying behavior better than knowing how many beds it has. Two facilities of the same size can have opposite purchasing autonomy depending on how centralized their parent system is.

Site-of-care mix is becoming a first-class variable rather than an afterthought. Teams selling into service lines that have shifted outpatient — orthopedics, cardiology diagnostics, oncology infusion, behavioral health — are finding that a facility's ambulatory footprint and outpatient volume matter more to their specific opportunity than its inpatient bed count ever did. Some teams are effectively building parallel account models: one for inpatient-anchored categories, another for outpatient-anchored ones, because a single bed-based score can't serve both well.

Technology and infrastructure signals are getting more attention as proxies for actual spend capacity — things like EHR platform, recent M&A activity, capital project announcements, or leadership changes in supply chain and IT. These tend to correlate with near-term purchasing behavior more directly than facility size does, because they reflect decisions already in motion rather than static physical capacity.

Specialty and service line depth is increasingly used to segment within a system rather than across systems, since a large system's purchasing decisions for, say, imaging equipment often get made at a regional or service-line level that cuts across individual facilities entirely.

None of these signals is a clean replacement for bed count as a single number — that's part of the point. The old model was attractive precisely because it collapsed a lot of complexity into one field you could sort a spreadsheet by. The honest state of the industry now is that purchasing power doesn't collapse into one field anymore, and pretending otherwise mostly serves the reporting deck, not the pipeline.

The Real Shift Is From Facility Size to Organizational Structure

The teams handling this well aren't hunting for a single new proxy metric to replace bed count — they've accepted that hospital purchasing power is now a function of organizational structure, not physical footprint, and they're building account models that reflect that. That means treating system affiliation, decision-making hierarchy, and site-of-care mix as core segmentation fields rather than enrichment fields bolted on after the fact. It's part of why data providers like NPLUS Global have leaned harder into mapping affiliation and hierarchy relationships rather than just facility attributes — because that's genuinely where the predictive signal has moved.

Bed count still tells you something. It's just no longer telling you the thing most commercial teams have historically assumed it was telling them — and the gap between those two things is exactly where a lot of misallocated sales and marketing spend is quietly happening.